頁面路徑選單
Healthcare Analytics/Medical Analytics Market by Application, Type, Delivery model, End-user - Global Forecast to 2020
出 版 商：MarketsandMarkets
出版日期：2015/07/27
頁 數：235頁
文件格式：PDF
價 格：
USD 4,650 (Single-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
The healthcare analytics market is categorized on the basis of type, component, delivery model, application, end user, and region. Factors such as the rising pressure to curb healthcare costs, big data in healthcare, technological advancements, growing awareness about benefits of analytics, and increase in venture capital investments are driving market growth. On the other hand, the operational gap between payers and providers, lack of skilled personnel, and high cost of analytics solutions may restrict market growth in the forecast period.
In the U.S., several initiatives have been taken to reduce the healthcare costs and improve patient care, such as the Meaningful Use incentives, U.S. federal government regulations (such as the ICD-10 coding standards, HIPAA, and PPACA). The need for hospitals to comply with federal healthcare mandates encourages them to use data analytics for decision-making, improving the quality of care, and preventing avoidable costs. The U.S.’s prominence in healthcare analytics is also boosting the growth of the North American market.
Apart from the comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, and change in strategic approach; R&D investments; and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the product portfolios of top players in the healthcare analytics market. The report analyzes the healthcare analytics market by type, application, component, delivery mode, end user, and region
‧ Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the healthcare analytics market
‧ Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in healthcare analytics market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for healthcare analytics across geographies
‧ Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the healthcare analytics market
In the U.S., several initiatives have been taken to reduce the healthcare costs and improve patient care, such as the Meaningful Use incentives, U.S. federal government regulations (such as the ICD-10 coding standards, HIPAA, and PPACA). The need for hospitals to comply with federal healthcare mandates encourages them to use data analytics for decision-making, improving the quality of care, and preventing avoidable costs. The U.S.’s prominence in healthcare analytics is also boosting the growth of the North American market.
Apart from the comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, and change in strategic approach; R&D investments; and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the product portfolios of top players in the healthcare analytics market. The report analyzes the healthcare analytics market by type, application, component, delivery mode, end user, and region
‧ Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the healthcare analytics market
‧ Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in healthcare analytics market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for healthcare analytics across geographies
‧ Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the healthcare analytics market
TABLE OF CONTENTS
1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 MARKET SIZE ESTIMATION 25
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.3 KEY DATA FROM SECONDARY SOURCES 29
2.4 KEY DATA FROM PRIMARY SOURCES 30
2.5 KEY INDUSTRY INSIGHTS 31
2.6 ASSUMPTIONS FOR THE STUDY 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 38
4.1 HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL 38
4.2 HEALTHCARE ANALYTICS MARKET, BY TYPE 39
4.3 HEALTHCARE ANALYTICS MARKET, BY FINANCIAL APPLICATION 39
4.4 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 40
4.5 HEALTHCARE ANALYTICS MARKET, BY END USER 41
4.6 GEOGRAPHIC SNAPSHOT OF THE HEALTHCARE ANALYTICS MARKET 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 44
5.2 MAKET SEGMENTATION 44
5.2.1 BY TYPE 44
5.2.2 BY APPLICATION 45
5.2.3 BY COMPONENT 45
5.2.4 BY DELIVERY MODEL 46
5.2.5 BY END USER 46
5.2.6 BY REGION 47
?
5.3 MARKET DYNAMICS 48
5.3.1 DRIVERS 49
5.3.1.1 Federal mandates 49
5.3.1.2 Rising pressure to curb healthcare spending and need for improve patient outcomes 49
5.3.1.3 Availability of big data in healthcare 50
5.3.1.4 Rise in venture capital investments 50
5.3.1.5 Technological advancements 51
5.3.2 RESTRAINTS 52
5.3.2.1 Dearth of skilled personnel 52
5.3.2.2 High cost of analytics solutions 52
5.3.2.3 Operational gap between payers and providers 52
5.3.3 OPPORTUNITIES 53
5.3.3.1 Precision medicine 53
5.3.3.2 Increasing focus on value-based medicine 54
5.3.3.3 Cloud-based healthcare analytics solutions 54
5.3.3.4 Increase in patient registries 54
5.3.4 CHALLENGES 56
5.3.4.1 Patient data confidentiality 56
5.3.4.2 Reluctance in adopting healthcare analytics in emerging economies 56
6 HEALTHCARE ANALYTICS MARKET, BY TYPE 57
6.1 INTRODUCTION 58
6.2 DESCRIPTIVE ANALYTICS 59
6.3 PREDICTIVE ANALYTICS 61
6.4 PRESCRIPTIVE ANALYTICS 63
7 HEALTHCARE ANALYTICS MARKET, BY APPLICATION 65
7.1 INTRODUCTION 66
7.2 CLINICAL ANALYTICS 66
7.2.1 POPULATION HEALTH MANAGEMENT 69
7.2.2 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING 71
7.2.3 COMPARATIVE ANALYTICS/COMPARATIVE EFFECTIVENESS 72
7.2.4 CLINICAL DECISION SUPPORT 74
7.2.5 PRECISION HEALTH 75
7.2.6 REGULATORY REPORTING AND COMPLIANCE 76
7.3 FINANCIAL ANALYTICS 78
7.3.1 REVENUE CYCLE MANAGEMENT 80
7.3.2 CLAIMS PROCESSING 81
7.3.3 PAYMENT INTEGRITY AND FRAUD WASTE & ABUSE (FWA) 83
7.3.3.1 Fraud Analytics: a lucrative market segment 85
7.3.3.2 Introduction 85
7.3.3.3 Market drivers 85
7.3.3.3.1 Prepayment review model 85
7.3.3.3.2 Awareness through conferences and market seminars 85
7.3.3.3.3 Technological advancements 86
7.3.3.3.4 High returns on investment 86
7.3.3.4 Market restraints 86
7.3.3.4.1 Lack of skilled professionals 86
7.3.3.4.2 Time-consuming deployment and frequent upgrades 87
7.3.3.5 Healthcare fraud analytics market analysis, by key players 87
7.3.3.6 Key players: product offerings 89
7.3.4 RISK ADJUSTMENT AND RISK ASSESSMENT 90
7.4 OPERATIONAL AND ADMINISTRATIVE ANALYTICS 92
7.4.1 SUPPLY CHAIN ANALYTICS 93
7.4.2 WORKFORCE ANALYTICS 95
7.4.3 STRATEGIC ANALYTICS 96
8 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 98
8.1 INTRODUCTION 99
8.2 SERVICES 100
8.2.1 SUPPORT SERVICES 101
8.2.2 BUSINESS ANALYTICS SERVICES 102
8.3 SOFTWARE 104
8.4 HARDWARE 106
9 HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL 108
9.1 INTRODUCTION 109
9.2 ON-PREMISE DELIVERY MODELS 110
9.3 ON-DEMAND DELIVERY MODELS 112
10 HEALTHCARE ANALYTICS MARKET, BY END USER 114
10.1 INTRODUCTION 115
10.2 PAYERS 116
10.2.1 PRIVATE INSURANCE COMPANIES 117
10.2.2 GOVERNMENT AGENCIES 118
10.2.3 EMPLOYERS & PRIVATE EXCHANGES 119
10.3 PROVIDERS 121
10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS (INTEGRATED DELIVERY NETWORKS) 122
10.3.2 AMBULATORY SETTINGS 124
10.4 ACOS, HIES, MCOS, AND TPAS 125
?
11 GEOGRAPHIC ANALYSIS 128
11.1 INTRODUCTION 129
11.2 NORTH AMERICA 130
11.2.1 U.S. 137
11.2.2 CANADA 143
11.3 EUROPE 149
11.4 ASIA 156
11.5 REST OF THE WORLD 164
12 COMPETITIVE LANDSCAPE 171
12.1 OVERVIEW 171
12.2 COMPETITIVE SITUATION AND TRENDS 174
12.2.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 174
12.2.2 NEW PRODUCT LAUNCHES 176
12.2.3 MERGERS AND ACQUISITIONS 177
12.2.4 EXPANSIONS 178
13 COMPANY PROFILES 179
13.1 INTRODUCTION 179
13.2 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 180
13.3 CERNER CORPORATION 183
13.4 HEALTH CATALYST 186
13.5 IBM CORPORATION 189
13.6 INOVALON 192
13.7 MCKESSON CORPORATION 194
13.8 MEDEANALYTICS, INC. 197
13.9 OPTUM, INC. (PART OF UNITEDHEALTH GROUP, INC.) 199
13.10 ORACLE CORPORATION 203
13.11 SAS INSTITUTE INC. 206
13.12 TRUVEN HEALTH ANALYTICS INC. 209
13.13 VERISK ANALYTICS, INC. 212
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
14 APPENDIX 215
14.1 INSIGHTS FROM INDUSTRY EXPERTS 215
14.2 DISCUSSION GUIDE 216
14.3 OTHER DEVELOPMENTS, BY COMPANY, 2012–2015 220
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 232
14.5 AVAILABLE CUSTOMIZATIONS 233
14.6 RELATED REPORTS 234
1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 MARKET SIZE ESTIMATION 25
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.3 KEY DATA FROM SECONDARY SOURCES 29
2.4 KEY DATA FROM PRIMARY SOURCES 30
2.5 KEY INDUSTRY INSIGHTS 31
2.6 ASSUMPTIONS FOR THE STUDY 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 38
4.1 HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL 38
4.2 HEALTHCARE ANALYTICS MARKET, BY TYPE 39
4.3 HEALTHCARE ANALYTICS MARKET, BY FINANCIAL APPLICATION 39
4.4 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 40
4.5 HEALTHCARE ANALYTICS MARKET, BY END USER 41
4.6 GEOGRAPHIC SNAPSHOT OF THE HEALTHCARE ANALYTICS MARKET 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 44
5.2 MAKET SEGMENTATION 44
5.2.1 BY TYPE 44
5.2.2 BY APPLICATION 45
5.2.3 BY COMPONENT 45
5.2.4 BY DELIVERY MODEL 46
5.2.5 BY END USER 46
5.2.6 BY REGION 47
?
5.3 MARKET DYNAMICS 48
5.3.1 DRIVERS 49
5.3.1.1 Federal mandates 49
5.3.1.2 Rising pressure to curb healthcare spending and need for improve patient outcomes 49
5.3.1.3 Availability of big data in healthcare 50
5.3.1.4 Rise in venture capital investments 50
5.3.1.5 Technological advancements 51
5.3.2 RESTRAINTS 52
5.3.2.1 Dearth of skilled personnel 52
5.3.2.2 High cost of analytics solutions 52
5.3.2.3 Operational gap between payers and providers 52
5.3.3 OPPORTUNITIES 53
5.3.3.1 Precision medicine 53
5.3.3.2 Increasing focus on value-based medicine 54
5.3.3.3 Cloud-based healthcare analytics solutions 54
5.3.3.4 Increase in patient registries 54
5.3.4 CHALLENGES 56
5.3.4.1 Patient data confidentiality 56
5.3.4.2 Reluctance in adopting healthcare analytics in emerging economies 56
6 HEALTHCARE ANALYTICS MARKET, BY TYPE 57
6.1 INTRODUCTION 58
6.2 DESCRIPTIVE ANALYTICS 59
6.3 PREDICTIVE ANALYTICS 61
6.4 PRESCRIPTIVE ANALYTICS 63
7 HEALTHCARE ANALYTICS MARKET, BY APPLICATION 65
7.1 INTRODUCTION 66
7.2 CLINICAL ANALYTICS 66
7.2.1 POPULATION HEALTH MANAGEMENT 69
7.2.2 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING 71
7.2.3 COMPARATIVE ANALYTICS/COMPARATIVE EFFECTIVENESS 72
7.2.4 CLINICAL DECISION SUPPORT 74
7.2.5 PRECISION HEALTH 75
7.2.6 REGULATORY REPORTING AND COMPLIANCE 76
7.3 FINANCIAL ANALYTICS 78
7.3.1 REVENUE CYCLE MANAGEMENT 80
7.3.2 CLAIMS PROCESSING 81
7.3.3 PAYMENT INTEGRITY AND FRAUD WASTE & ABUSE (FWA) 83
7.3.3.1 Fraud Analytics: a lucrative market segment 85
7.3.3.2 Introduction 85
7.3.3.3 Market drivers 85
7.3.3.3.1 Prepayment review model 85
7.3.3.3.2 Awareness through conferences and market seminars 85
7.3.3.3.3 Technological advancements 86
7.3.3.3.4 High returns on investment 86
7.3.3.4 Market restraints 86
7.3.3.4.1 Lack of skilled professionals 86
7.3.3.4.2 Time-consuming deployment and frequent upgrades 87
7.3.3.5 Healthcare fraud analytics market analysis, by key players 87
7.3.3.6 Key players: product offerings 89
7.3.4 RISK ADJUSTMENT AND RISK ASSESSMENT 90
7.4 OPERATIONAL AND ADMINISTRATIVE ANALYTICS 92
7.4.1 SUPPLY CHAIN ANALYTICS 93
7.4.2 WORKFORCE ANALYTICS 95
7.4.3 STRATEGIC ANALYTICS 96
8 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 98
8.1 INTRODUCTION 99
8.2 SERVICES 100
8.2.1 SUPPORT SERVICES 101
8.2.2 BUSINESS ANALYTICS SERVICES 102
8.3 SOFTWARE 104
8.4 HARDWARE 106
9 HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL 108
9.1 INTRODUCTION 109
9.2 ON-PREMISE DELIVERY MODELS 110
9.3 ON-DEMAND DELIVERY MODELS 112
10 HEALTHCARE ANALYTICS MARKET, BY END USER 114
10.1 INTRODUCTION 115
10.2 PAYERS 116
10.2.1 PRIVATE INSURANCE COMPANIES 117
10.2.2 GOVERNMENT AGENCIES 118
10.2.3 EMPLOYERS & PRIVATE EXCHANGES 119
10.3 PROVIDERS 121
10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS (INTEGRATED DELIVERY NETWORKS) 122
10.3.2 AMBULATORY SETTINGS 124
10.4 ACOS, HIES, MCOS, AND TPAS 125
?
11 GEOGRAPHIC ANALYSIS 128
11.1 INTRODUCTION 129
11.2 NORTH AMERICA 130
11.2.1 U.S. 137
11.2.2 CANADA 143
11.3 EUROPE 149
11.4 ASIA 156
11.5 REST OF THE WORLD 164
12 COMPETITIVE LANDSCAPE 171
12.1 OVERVIEW 171
12.2 COMPETITIVE SITUATION AND TRENDS 174
12.2.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 174
12.2.2 NEW PRODUCT LAUNCHES 176
12.2.3 MERGERS AND ACQUISITIONS 177
12.2.4 EXPANSIONS 178
13 COMPANY PROFILES 179
13.1 INTRODUCTION 179
13.2 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 180
13.3 CERNER CORPORATION 183
13.4 HEALTH CATALYST 186
13.5 IBM CORPORATION 189
13.6 INOVALON 192
13.7 MCKESSON CORPORATION 194
13.8 MEDEANALYTICS, INC. 197
13.9 OPTUM, INC. (PART OF UNITEDHEALTH GROUP, INC.) 199
13.10 ORACLE CORPORATION 203
13.11 SAS INSTITUTE INC. 206
13.12 TRUVEN HEALTH ANALYTICS INC. 209
13.13 VERISK ANALYTICS, INC. 212
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
14 APPENDIX 215
14.1 INSIGHTS FROM INDUSTRY EXPERTS 215
14.2 DISCUSSION GUIDE 216
14.3 OTHER DEVELOPMENTS, BY COMPANY, 2012–2015 220
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 232
14.5 AVAILABLE CUSTOMIZATIONS 233
14.6 RELATED REPORTS 234
